Antiallergic Non-Drug Supplement Market is anticipated to grow at a significant CAGR during the forecast period. An antiallergic non-drug supplement is a medicinal product that includes various types of nutritional supplements, oils, among others. These supplements are categorized into tablets, capsules, and liquid dosage forms. Antiallergic non-drug supplements can alleviate various types of allergic symptoms and enable allergic patients to deal with the allergic symptoms without using any chemical-based formulations for the treatment.


The increasing prevalence of various allergic conditions such as fever, cough, cold, watery eyes, itching, sneezing, and others is anticipated to create new opportunities for the global antiallergic non-drug supplement market. The rising consumer preference to adopt natural and plant-based supplements is further expected to boost the growth of the global antiallergic non-drug supplement market. Additionally, the harmful effects associated with the use of chemical-based supplements is expected to surge the demand for non-drug supplement to treat several allergic conditions is further driving the market growth.

Some market players such as General Nutrition Centre Holdings, LLC (GNC), Emerald Laboratories, and others have been adopted various strategies to boost the market. Technological advancement, new product launches, and mergers & acquisitions, among others, are some key strategies that are adopted by key vendors to remain competitive in the market. In addition, some research institutes are also working in this area. For instance, in April 2021, National Center for Complementary and Integrative Health (NCCIH) announced that butterbur is used to treat migraines and hay fever, also known as allergic rhinitis, and efficiently relieve allergic symptoms. Butterbur is one of the most promising non-drug antiallergic supplements useful in some allergy drugs formulations.

To Request a Sample of our Report on Antiallergic Non-Drug Supplement Market: https://www.omrglobal.com/request-sample/antiallergic-non-drug-supplement-market

Market Coverage

· The market number available for – 2023-2030

· Base year- 2023

· Forecast period- 2024-2031

· Segment Covered

· Regions Covered- Globally

Competitive Landscape- General Nutrition Center Holdings, LLC (GNC), Emerald Laboratories, and others.

A full Report of Antiallergic Non-Drug Supplement Market is Available @ https://www.omrglobal.com/industry-reports/antiallergic-non-drug-supplement-market

Antiallergic Non-Drug Supplement Market Report Segmentation

By Product

· Capsules

· Tablets

· Liquids

By Application

· Pollen Allergy

· Dust Mites Allergy

· Others

Antiallergic Non-Drug Supplement Market by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

• Latin America

• Middle East and Africa

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antiallergic-non-drug-supplement-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 7803040404